Robert W. McMahon is the Senior Vice President and Chief Financial Officer of West Pharmaceutical Services, Inc., a global leader in designing and manufacturing advanced systems and components for the safe, effective delivery of injectable drugs and therapies. With more than 25 years of finance and leadership experience, McMahon plays a pivotal role in steering the company's financial strategy, capital allocation, investor relations, and risk management, ensuring sustained growth and operational excellence in a highly regulated industry. McMahon joined West in 2001 as Vice President, Finance and Treasurer, after holding senior finance positions at ARCO Chemical Company (now LyondellBasell Industries), where he served as Director of Finance for the Performance Chemicals Division and in various treasury and planning roles. He earned a Bachelor of Science in Accounting from Villanova University and a Master of Business Administration from Drexel University, providing a strong foundation for his expertise in financial planning, mergers and acquisitions, and corporate development. Since ascending to CFO in 2007, McMahon has overseen transformative achievements, including navigating the company through economic cycles, funding global expansions, and supporting revenue growth from approximately $700 million to over $2.9 billion by 2023. His strategic leadership has bolstered West's financial resilience, earned recognition for strong corporate governance, and positioned the company for innovation in drug delivery technologies amid rising demand for biologics and personalized medicine.